High Tower Advisors, LLC Abbott Laboratories Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, High Tower Advisors, LLC holds 1,959,969 shares of ABT stock, worth $220 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

1,959,969

Previous 2,093,158 6.36%

Holding current value

$220 Million

Previous $238 Million 14.4%

% of portfolio

0.32%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $13.4 Million - $15 Million	-133,189 Reduced 6.36%	1,959,969 $204 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $8.21 Million - $9.07 Million	74,954 Added 3.71%	2,093,158 $238 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $10 Million - $12.3 Million	111,062 Added 5.82%	2,018,204 $222 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $39.5 Million - $47.4 Million	413,274 Added 27.66%	1,907,142 $185 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $3.96 Million - $4.41 Million	39,297 Added 2.7%	1,493,868 $163 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $870,383 - $1.02 Million	-8,986 Reduced 0.61%	1,454,571 $147 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $1.55 Million - $1.82 Million	-16,279 Reduced 1.1%	1,463,557 $161 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $1.3 Million - $1.51 Million	13,434 Added 0.92%	1,479,836 $143 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $3.69 Million - $4.46 Million	-36,166 Reduced 2.41%	1,466,402 $159 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $4.55 Million - $5.55 Million	39,933 Added 2.73%	1,502,568 $178 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $39.8 Million - $48.7 Million	344,545 Added 30.82%	1,462,635 $206 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2.63 Million - $2.91 Million	22,543 Added 2.06%	1,118,090 $132 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $6.79 Million - $8 Million	64,225 Added 6.23%	1,095,547 $127 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $1.56 Million - $1.84 Million	-14,339 Reduced 1.37%	1,031,322 $124 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $8.57 Million - $9.34 Million	81,662 Added 8.47%	1,045,661 $114 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $12.8 Million - $15.6 Million	139,788 Added 16.96%	963,999 $105 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $1.55 Million - $1.98 Million	20,230 Added 2.52%	824,211 $75.3 Million
Q1 2020 May 21, 2020	BUY	$62.82 - $91.86 $50.5 Million - $73.9 Million	803,981 New	803,981 $63.5 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $54.5 Million - $60.7 Million	-694,180 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $1 Million - $1.09 Million	-12,247 Reduced 1.73%	694,180 $58.1 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $472,116 - $550,630	6,478 Added 0.93%	706,427 $59.4 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $1.5 Million - $1.82 Million	-22,706 Reduced 3.14%	699,949 $56 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $11.2 Million - $12.7 Million	170,708 Added 30.93%	722,655 $52.2 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $1.55 Million - $1.87 Million	25,443 Added 4.83%	551,947 $40.5 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $254,229 - $280,592	-4,416 Reduced 0.83%	526,504 $32.1 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $2.49 Million - $2.82 Million	44,277 Added 9.1%	530,920 $31.8 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $7.34 Million - $7.86 Million	-136,741 Reduced 21.94%	486,643 $27.8 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $31,815 - $35,509	662 Added 0.11%	623,384 $33.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	622,722	622,722 $30.3 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Abbott Laboratories Transaction History